ŠMAJS, David, Lenka PAŠTĚKOVÁ and Linda GRILLOVÁ. Macrolide Resistance in the Syphilis Spirochete, Treponema pallidum ssp. pallidum: Can We Also Expect Macrolide-Resistant Yaws Strains? American Journal of Tropical Medicine and Hygiene. McLean: American Society of Tropical Medicine and Hygiene, 2015, vol. 93, No 4, p. 678-683. ISSN 0002-9637. Available from: https://dx.doi.org/10.4269/ajtmh.15-0316.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Macrolide Resistance in the Syphilis Spirochete, Treponema pallidum ssp. pallidum: Can We Also Expect Macrolide-Resistant Yaws Strains?
Authors ŠMAJS, David (203 Czech Republic, guarantor, belonging to the institution), Lenka PAŠTĚKOVÁ (203 Czech Republic, belonging to the institution) and Linda GRILLOVÁ (203 Czech Republic, belonging to the institution).
Edition American Journal of Tropical Medicine and Hygiene, McLean, American Society of Tropical Medicine and Hygiene, 2015, 0002-9637.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30300 3.3 Health sciences
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 2.453
RIV identification code RIV/00216224:14110/15:00081041
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.4269/ajtmh.15-0316
UT WoS 000362311800003
Keywords in English SINGLE-DOSE AZITHROMYCIN; COMPLETE GENOME SEQUENCE; RIBOSOMAL-RNA GENES; HUMAN-IMMUNODEFICIENCY-VIRUS; PENICILLIN-BINDING PROTEIN; TIME MULTIPLEX PCR; SECONDARY SYPHILIS; TREATMENT FAILURE; POINT MUTATION; ERYTHROMYCIN RESISTANCE
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Ing. Mgr. Věra Pospíšilíková, učo 9005. Changed: 5/1/2016 13:42.
Abstract
Treponema pallidum ssp. pallidum (TPA) causes over 10 million new cases of syphilis worldwide whereas T. pallidum ssp. pertenue (TPE), the causative agent of yaws, affects about 2.5 million people. Although penicillin remains the drug of choice in the treatment of syphilis, in penicillin-allergic patients, macrolides have been used in this indication since the 1950s. Failures of macrolides in syphilis treatment have been well documented in the literature and since 2000, there has been a dramatic increase in a number of clinical samples with macrolide-resistant TPA. Scarce data regarding the genetics of macrolide-resistant mutations in TPA suggest that although macrolideresistance mutations have emerged independently several times, the increase in the proportion of TPA strains resistant to macrolides is mainly due to the spread of resistant strains, especially in developed countries. The emergence of macrolide resistance in TPA appears to require a two-step process including either A2058G or A2059G mutation in one copy of the 23S rRNA gene and a subsequent gene conversion unification of both rRNA genes. Given the enormous genetic similarity that was recently revealed between TPA and TPE strains, there is a low but reasonable risk of emergence and spread of macrolide-resistant yaws strains following azithromycin treatment.
Links
GAP302/12/0574, research and development projectName: Celogenomové sekvencování v analýze genomů a transkriptomů patogenních bakterií rodu Treponema
Investor: Czech Science Foundation
PrintDisplayed: 24/8/2024 06:15